Gene · 93
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The miRNA Profile of Inflammatory Colorectal Tumors Identify TGF-β as a Companion Target for Checkpoint Blockade Immunotherapy. | Front Cell Dev Biol | 2021 | 34722540 | PubTator, text mining | PubMed |
| LncRNAs in the Regulation of Genes and Signaling Pathways through miRNA-Mediated and Other Mechanisms in Clear Cell Renal Cell Carcinoma. | Int J Mol Sci | 2021 | 34681854 | PubTator, text mining | PubMed |
| Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC. | Biomedicines | 2021 | 34680503 | PubTator, text mining | PubMed |
| Myostatin and Follistatin-New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications. | Biomedicines | 2021 | 34680417 | PubTator, text mining | PubMed |
| Epigallocatechin-3-Gallate Suppresses BMP-6-Mediated SMAD1/5/8 Transactivation of Hepcidin Gene by Inducing SMILE in Hepatocytes. | Antioxidants (Basel) | 2021 | 34679725 | PubTator, text mining | PubMed |
| Fibroblast growth factor 2 suppresses the expression of C-C motif chemokine 11 through the c-Jun N-terminal kinase pathway in human dental pulp-derived mesenchymal stem cells. | Exp Ther Med | 2021 | 34659502 | PubTator, text mining | PubMed |
| The Exploration of Poor Ovarian Response-Related Risk Factors: A Potential Role of Growth Differentiation Factor 8 in Predicting Ovarian Response in IVF-ET Patient. | Front Endocrinol (Lausanne) | 2021 | 34630324 | PubTator, text mining | PubMed |
| Copy number variation analysis in Chinese children with complete atrioventricular canal and single ventricle. | BMC Med Genomics | 2021 | 34627233 | PubTator, text mining | PubMed |
| Huntingtin CAG expansion impairs germ layer patterning in synthetic human 2D gastruloids through polarity defects. | Development | 2021 | 34608934 | PubTator, text mining | PubMed |
| LHPP suppresses colorectal cancer cell migration and invasion in vitro and in vivo by inhibiting Smad3 phosphorylation in the TGF-β pathway. | Cell Death Discov | 2021 | 34608127 | PubTator, text mining | PubMed |
| Skeletal Muscle Deconditioning in Breast Cancer Patients Undergoing Chemotherapy: Current Knowledge and Insights From Other Cancers. | Front Cell Dev Biol | 2021 | 34595171 | PubTator, text mining | PubMed |
| Novel MYO1D Missense Variant Identified Through Whole Exome Sequencing and Computational Biology Analysis Expands the Spectrum of Causal Genes of Laterality Defects. | Front Med (Lausanne) | 2021 | 34589502 | PubTator, text mining | PubMed |
| Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives. | Nutrients | 2021 | 34579079 | PubTator, text mining | PubMed |
| Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease. | Life (Basel) | 2021 | 34575048 | PubTator, text mining | PubMed |
| The Effect of Acute and Chronic Thermotherapy on Type 2 Diabetic Skeletal Muscle Gene Expression and Inflammatory Markers. | Biomedicines | 2021 | 34572462 | PubTator, text mining | PubMed |
| JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology. | Pediatr Rheumatol Online J | 2021 | 34563217 | PubTator, text mining | PubMed |
| MicroRNA-21: An Emerging Player in Bone Diseases. | Front Pharmacol | 2021 | 34557095 | PubTator, text mining | PubMed |
| Advances in research on pharmacotherapy of sarcopenia. | Aging Med (Milton) | 2021 | 34553120 | PubTator, text mining | PubMed |
| Integrated Bioinformatic Analysis of Competing Endogenous RNA Network of Choriocarcinoma. | Med Sci Monit | 2021 | 34538870 | PubTator, text mining | PubMed |
| [Myokines and adipomyokines: inflammatory mediators or unique molecules of targeted therapy for obesity?] | Probl Endokrinol (Mosk) | 2021 | 34533012 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/93/papers?page=22